RetaMaps

Advanced Wellness Clinic

Advanced Wellness Clinic · 6301 Ivy Lane · Greenbelt, MD 20770

5.0· 124 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

About this practice

Advanced Wellness Clinic is a hybrid direct primary care clinic in Greenbelt, Maryland. Its website describes on-demand, unlimited access to care without insurance, with transparent pricing, covering primary care, sick visits, medical weight loss, wellness injections and IV therapy, and says tirzepatide may be part of a medically supervised weight-loss program. The site names Banis Githinji, DNP. On Google it has a 5.0-star rating across 124 reviews dating back to 2025, with 53 posted in the past year. Reviewers most often mention the providers' knowledge and the staff, and 13 mention feeling cared for.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsNot listed
Cash pay accepted—
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 5.0
Google rating · 124 reviews
53
reviews in the past year (avg ★ 5.0)
7
reviews mention weight loss

Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-02. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★5.0 across 124 Google reviews. Of the 100 reviews we analyzed, 100 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).

What patients like

  • Knowledgeable, professional providers27 reviews
  • Friendly, helpful staff25 reviews
  • Feeling listened to14 reviews
  • Clean, comfortable office13 reviews

Common complaints

No negative reviews among those we analyzed.

5★
100
4★
0
3★
0
2★
0
1★
0

Most recent Google reviews

Samwel O.★★★★★2026-09-02

My experience at the clinic was by far the best I've received anywhere. From the admin staff to the doctor, my needs were fully met. I highly recommend this clinic!

Shirley E.★★★★★2026-08-24

I just love the doctor she is so nice Listen to you and very patient. The staff was very nice.

Brenton F.★★★★★2026-08-22

Everyone who are working in this office, I appreciate them all, I have never seen politeness in any business environment, like this office, such a wonderful group of professionals. Keep up the great work…

Denice S.★★★★★2026-08-05

Great experience! They were very welcoming and the staff were professional. The team member Roxana was especially nice, and took the time to answer all of my questions.

Pauline P.★★★★★2026-07-31

I had great experience with Dr. Banis she was professional kind and very supportive with no judgment she took the time to really listen and explained everything clearly and created a plan that will work for me I felt encouraged the staff are very pleasant and helpful the whole visit.Highly recommend!

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Nearby providers in Greenbelt

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs